Detection of pandrug-resistant ST15 Acinetobacter baumannii causing bloodstream infection in an HSCT patient in Brazil.

[1]  A. C. Narciso,et al.  Genetic Characterization of Plasmid-Borne blaOXA-58 in Distinct Acinetobacter Species , 2019, mSphere.

[2]  L. Leibovici,et al.  Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Nastro,et al.  Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America. , 2018, Revista Argentina de microbiologia.

[4]  W. Lima,et al.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  M. Nastro,et al.  Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America. , 2016, Journal of medical microbiology.

[6]  R. Hall,et al.  Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene. , 2016, The Journal of antimicrobial chemotherapy.

[7]  C. H. Camargo,et al.  Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  R. Albano,et al.  Draft genome sequence of a multidrug-resistant Acinetobacter baumannii ST15 (CC15) isolated from Brazil , 2015, Memorias do Instituto Oswaldo Cruz.

[9]  A. Marra,et al.  Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study , 2011, Journal of Clinical Microbiology.